Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign

SAN DIEGO--(BUSINESS WIRE)--Nov 2, 2026--

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today launched A Letter to Diabetes in honor of National Diabetes Awareness Month and World Diabetes Day, creating a platform for people around the world to put into words everything they’ve wanted to say about their diabetes journey, from the heartfelt and humorous to the hopeful and unexpected.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261102328208/en/

Throughout November, anyone touched by diabetes is invited to share their own letter to diabetes, including people living with the condition, caregivers, loved ones and healthcare professionals. Dexcom and voices from across the diabetes community will help bring these stories to a global stage, spotlighting the many different experiences of diabetes and creating a space for people to be seen and heard.

Together, these individual letters become something bigger: a celebration of the people, relationships and community that remind us that no one navigates diabetes alone. Because while diabetes may be part of someone’s story, it’s never their whole story.

Among those sharing their stories is multi-platinum recording artist, songwriter, actor and co-founder of Beyond Type 1 Nick Jonas, who has lived with type 1 diabetes for more than 20 years. In a deeply personal letter reflecting on his relationship with the condition, Jonas opens up about the challenges, lessons and emotions that have shaped his journey.

In an excerpt from his letter, Jonas writes:

“Diabetes, when we first met, your unpredictability threw me. I’d built my whole life around this unrealistic structure and belief that I was in control. You took that apart over the years, bit by bit. Part of me is grateful I learned that lesson. Part of me resents you for it. I never wanted to be a victim, or to come across like one. I share my story for the 13-year-old who just got diagnosed and is lying in a hospital bed, scared to death. I want them to see someone out there living their dreams while managing this, every single day.”

Across the diabetes community, strength takes many forms. From navigating the daily realities of diabetes to celebrating the small victories along the way. Chris Megino, who has built a supportive online social following, reflected on the lessons he’s learned throughout his 30-year journey with type 2 diabetes:

“Diabetes, if there’s anything you’ve taught me, it’s that strength isn’t about never struggling, it’s about showing up anyway. It’s the small wins. The workout you didn’t feel like doing. The better glucose reading. The family that supports you. So, diabetes, I’m not going to thank you for everything you put me through. But will thank you for teaching me something about myself and showing me I’m more capable than I thought.”

For others, the impact of diabetes extends beyond their own experience, shaping the lives of the people they love most. Chelsea Lugone, a nurse practitioner and diabetes care and education specialist at Dexcom who lives with type 1 diabetes and is the mother of two children who also have the condition, wrote:

“As much as you have shaped me, diabetes, I would give anything for you to disappear, especially from the lives of my children, Kate and Ryan. Living with diabetes is one thing, but watching my children live with it is something entirely different.For now, I will keep doing my best – for myself, for my children – leaning into our community and those who support us. I will continue to live the best life I can – reminding myself and others who are impacted by you that we are more than you – we are more than a number and we always will be.”

More than 589 million people worldwide live with diabetes 1, and each has a story to share. To submit your letter to diabetes and explore stories from people impacted by diabetes around the world, visit ALetterToDiabetes.com.*

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

1 IDF Atlas, 11thedition (2025)

*Stories will be reviewed before posting, and while we value every submission, not all stories will be published

Visit ALetterToDiabetes.com to explore stories from people impacted by diabetes around the world and submit your own letter.

U.S. futures are rebounding from a major market sell-off Friday with a boost from sharply declining oil prices on hopes for progress in diplomatic efforts between the U.S. and Iran.

Futures for the S&P 500 advanced 0.5% Monday, while those for the Dow Jones Industrial Average rose 0.6%. Nasdaq futures rose 0.8%.

U.S. stocks fell Friday in their worst day since June as investors dumped artificial intelligence and tech stocks. There is growing concern that the massive investments in AI will not pay off, at least not fast enough.

Apple will report its latest earnings results after the bell Monday along with Palantir Technologies. Advanced Micro Devices will report its quarterly results on Tuesday.

Last week, earnings reports from Google parent Alphabet Inc. and Amazon rattled markets and raised fresh questions over whether their massive AI-related spending.

Shares of both Marvell and Lumentum are falling after the announcement of an all-stock deal for Lumentum worth about $115 billion, including debt. Marvell, despite the aggressive pullback in AI stocks last week, believes the investment is still warranted.

Markets appear less certain. Marvell slid more than 1% before the opening bell and Lumentum fell almost 3%.

Oil prices dropped Monday, with Brent crude, the international standard, down 4.2% to $108.68 per barrel. Still, that’s much higher than the roughly $65 that a barrel of crude was selling for at this time last year.

Benchmark U.S. crude fell 4.2%, to $99.74 a barrel, compared with $61 per barrel at this time last February.

Iran’s top diplomat said in an interview shared on his Telegram channel over the weekend that Iranian negotiators were in Qatar for talks on a proposal that could reopen the Strait of Hormuz within two days if the U.S. meets several conditions. However, he said no direct talks were being held with the U.S.

The final outcome of the diplomatic efforts to avoid a return to all-out war depends on answers provided by the United States to the “Iranian questions,” he said.

Wall Street is also waiting for the outcome of Tuesday’s U.S. midterm elections. Voters across the political spectrum have shown increasing concerns about AI and data centers, along with inflation and other key issues.

There is critical U.S. economic data arriving Friday when the government issues its October jobs report. In September, U.S. employers added a disappointing 29,000 jobs and the unemployment rate ticked up to a still-low 4.2%.

In equities trading, shares of both Marvell and Lumentum are falling after an all-stock deal for Lumentum worth about $115 billion, including debt. Marvell, despite an aggressive pullback in AI stocks last week, believes the investment environment is still active.

Markets appear less certain. Marvell slid more than 1% before the opening bell and Lumentum fell almost 3%.

In Europe, Britain's FTSE 100 gained 0.1% to 10,736.14 on Monday. Germany's DAX climbed 0.1% to 25,847.97, while the CAC 40 in Paris added 0.2% to 7,988.21. Asian markets were mostly higher.

The U.S. dollar rose to 157.91 Japanese yen from 157.49 yen. The euro was trading at $1.1211, up from $1.1160.

FILE - Trader Michael Capolino, left, and Specialist Thomas McArdle work on the floor of the New York Stock Exchange, Monday, Jan. 26, 2026. (AP Photo/Richard Drew, file)

A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm, Monday, Nov. 2, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm, Monday, Nov. 2, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm, Monday, Nov. 2, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walks in front of an electronic stock board showing Japan's Nikkei and New York Dow indexes at a securities firm, Monday, Nov. 2, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm, Monday, Nov. 2, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)